Banco Santander S.A. Sells 17,684 Shares of Cardinal Health, Inc. $CAH

Banco Santander S.A. cut its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 15.1% during the 4th quarter, HoldingsChannel reports. The firm owned 99,670 shares of the company’s stock after selling 17,684 shares during the period. Banco Santander S.A.’s holdings in Cardinal Health were worth $20,482,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Redhawk Wealth Advisors Inc. grew its holdings in Cardinal Health by 0.5% during the 4th quarter. Redhawk Wealth Advisors Inc. now owns 9,255 shares of the company’s stock worth $1,902,000 after acquiring an additional 48 shares during the last quarter. HF Advisory Group LLC grew its holdings in Cardinal Health by 0.9% during the 4th quarter. HF Advisory Group LLC now owns 5,227 shares of the company’s stock worth $1,074,000 after acquiring an additional 49 shares during the last quarter. Hillsdale Investment Management Inc. grew its holdings in Cardinal Health by 0.9% during the 4th quarter. Hillsdale Investment Management Inc. now owns 5,760 shares of the company’s stock worth $1,184,000 after acquiring an additional 50 shares during the last quarter. Generali Asset Management SPA SGR grew its holdings in Cardinal Health by 11.0% during the 4th quarter. Generali Asset Management SPA SGR now owns 513 shares of the company’s stock worth $105,000 after acquiring an additional 51 shares during the last quarter. Finally, Stephens Inc. AR grew its holdings in Cardinal Health by 0.9% during the 4th quarter. Stephens Inc. AR now owns 5,951 shares of the company’s stock worth $1,223,000 after acquiring an additional 52 shares during the last quarter. 87.17% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on CAH shares. Evercore reduced their price objective on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 8th. Leerink Partners reaffirmed an “outperform” rating and set a $275.00 price objective on shares of Cardinal Health in a research report on Monday, March 9th. William Blair started coverage on shares of Cardinal Health in a research note on Tuesday, April 28th. They set an “outperform” rating on the stock. Barclays increased their target price on shares of Cardinal Health from $243.00 to $258.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 24th. Finally, Wells Fargo & Company cut their target price on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $246.93.

Cardinal Health Stock Performance

Shares of CAH opened at $223.76 on Friday. The firm has a market cap of $52.41 billion, a price-to-earnings ratio of 34.21, a PEG ratio of 1.21 and a beta of 0.52. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $233.60. The firm has a 50 day moving average price of $203.21 and a 200-day moving average price of $208.85.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping the consensus estimate of $2.79 by $0.38. The company had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the previous year, the firm earned $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities research analysts predict that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be paid a dividend of $0.5158 per share. The ex-dividend date is Wednesday, July 1st. This represents a $2.06 annualized dividend and a yield of 0.9%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio (DPR) is currently 31.19%.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.